Elanco Animal Health (ELAN) Equity Average (2017 - 2026)

Elanco Animal Health has disclosed Equity Average across 10 years of filings, most recently posting $6.5 billion for Q1 2026.

• Equity Average for Q1 2026 came in at $6.5 billion, up 4.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.5 billion (up 4.8% YoY), and the FY2025 annual result was $6.3 billion, up 2.63% from the prior year.
• Equity Average came in at $6.5 billion for Q1 2026 at Elanco Animal Health, down from $6.6 billion in the prior quarter.
• In the past five years, Equity Average ranged from a high of $7.5 billion in Q1 2022 to a low of $6.0 billion in Q2 2024.
• The 5-year median for Equity Average is $6.6 billion (2025), against an average of $6.7 billion.
• Across the five-year window, Equity Average retreated 19.48% in 2024 and increased 9.42% in 2025, its largest moves.
• Elanco Animal Health's Equity Average stood at $7.0 billion in 2022, then retreated by 11.75% to $6.2 billion in 2023, then grew by 2.12% to $6.3 billion in 2024, then rose by 5.36% to $6.6 billion in 2025, then decreased by 1.87% to $6.5 billion in 2026.
• The last three Equity Average figures came in at $6.5 billion (Q1 2026), $6.6 billion (Q4 2025), and $6.8 billion (Q3 2025), per Business Quant data.